Most recent technology transfer projects
| Funding authority | Programme | Title | Period |
|---|---|---|---|
| Crowdfunding | https://www.gofundme.com | Development of an enzyme replacement therapy for the treatment of transglutaminase-1-deficient autosomal recessive congenital ichthyosis (FMP, Margitta Dathe and WWU, Heiko Traupe) | Ongoing |
| Leibniz Association | Leibniz-Transfer | Cystein‐selective bioconjugation for next generation antibody drug conjugates (Christian Hackenberger/FMP) | 03.2018 - 12.2022 |
| Federal Ministry of Education and Research (BMBF) | Targetvalidierung für die pharmazeutische Wirkstoffentwicklung | Evaluating Ena/VASP as a novel relevant drug target for treatment of cancer metastasis (FMP, Ronald Kühne and University of Cologne, Hans-Günther Schmalz) | 01.2018 - 04.2020 |
| Bavarian Ministry of Economic Affairs and Media, Energy and Technology | m4 Award | Development of a Tubulis Technologies proprietary ADC for Acute Myeloid Leukemia treatment (Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt/LMU and Christian Hackenberger/FMP) | 01.2018 - 12.2019 |
| Federal Ministry for Economic Affairs and Energy (BMWi) | EXIST Forschungstransfer I | Tubulis Technologies, a pre-start-up project affiliated with the Ludwig Maximilians University Munich (LMU, Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt) and the FMP (Christian Hackenberger) | 04.2017 - 09.2019 |
| The Michael J. Fox Foundation | Improved Biomarkers & Clinical Outcome Measures - Spring 2016 Program | Supramolecular hosts as combined protein aggregation inhibitors and hyperpolarized MRI reporters, Leif Schröder | 09.2016 - 03.2019 |
| Human Frontier Science Program (HFSP) | Program Grant | Imaging cellular function noninvasively with genetically engineered reporters for hyperpolarized MRI, Leif Schröder, FMP & Mikhail Shapiro, Caltech, USA | 05.2016 - 04.2019 |
